InsiderTrades

Form 4 for CMMB Chemomab Therapeutics Ltd.

Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-14 · accession 0001178913-22-001179 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-21 2022-03-14 CMMB Marvin Donald CFO, COO, Executive VP P - Purchase $4.04 +1,250 500 New +$5,045
D 2022-03-21 2021-11-08 CMMB Marvin Donald CFO, COO, Executive VP A - Grant $0.00 +196.9K 196.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common American Depositary Shares 2022-03-14 P A 250 $3.90 1,000 D — — (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
2 Common American Depositary Shares 2022-03-14 P A 250 $4.10 1,250 D — — (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
3 Common American Depositary Shares 2022-03-14 P A 250 $4.20 1,500 D — — (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
4 Common American Depositary Shares 2022-03-14 P A 250 $4.00 250 D — — (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
5 Common American Depositary Shares 2022-03-14 P A 250 $3.98 500 D — — (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
6 Derivative Option to Purchase American Depositary Shares 2021-11-08 A A 196,875 $0.00 196,875 D $9.77 · — to 2021-11-08 196,875 American Depositary Shares (F2) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. (F3) The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.